Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Gibson

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Circulation|June 14, 2000
High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14S A Coulter, C P Cannon, K A Ault, et al.
Circulation|January 25, 2000
Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trialJ A de Lemos, E M Antman, C M Gibson, et al.
Circulation|December 22, 1998
TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B InvestigatorsC P Cannon, C M Gibson, C H McCabe, et al.
Journal of the American College of Cardiology|November 7, 1999
Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial InfarctionC M Gibson, S Murphy, I B Menown, et al.
Circulation|June 3, 1999
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 InvestigatorsE M Antman, R P Giugliano, C M Gibson, et al.
European Heart Journal|November 10, 2000
Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 InvestigatorsE M Antman, C M Gibson, J A de Lemos, et al.
Heart (British Cardiac Society)|May 14, 2008
Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysisG De Luca, C M Gibson, F Bellandi, et al.
NEJM Evidence|November 10, 2025
Zalunfiban at First Medical Contact for ST-Elevation Myocardial InfarctionA W J Van't Hof, C M Gibson, S A O F Rikken, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Circulation|June 14, 2000
High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14S A Coulter, C P Cannon, K A Ault, et al.
Circulation|January 25, 2000
Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trialJ A de Lemos, E M Antman, C M Gibson, et al.
Circulation|December 22, 1998
TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B InvestigatorsC P Cannon, C M Gibson, C H McCabe, et al.
Journal of the American College of Cardiology|November 7, 1999
Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial InfarctionC M Gibson, S Murphy, I B Menown, et al.
Circulation|June 3, 1999
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 InvestigatorsE M Antman, R P Giugliano, C M Gibson, et al.
European Heart Journal|November 10, 2000
Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 InvestigatorsE M Antman, C M Gibson, J A de Lemos, et al.
Heart (British Cardiac Society)|May 14, 2008
Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysisG De Luca, C M Gibson, F Bellandi, et al.
NEJM Evidence|November 10, 2025
Zalunfiban at First Medical Contact for ST-Elevation Myocardial InfarctionA W J Van't Hof, C M Gibson, S A O F Rikken, et al.
Pageof 10